1. Fountain NB, Adams RE. Midazolam treatment of acute and refractory status epilepticus. Clin Neuropharmacol. 1999;22(5):261–7.
2. Ulgey A, Aksu R, Bicer C. Nasal and buccal treatment of midazolam in epileptic seizures in pediatrics. Clin Med Insights Pediatr. 2012;6:51–60.
3. Lee JI, Chaves-Gnecco D, Amico JA, Kroboth PD, Wilson JW, Frye RF. Application of semisimultaneous midazolam administration for hepatic and intestinal cytochrome P450 3A phenotyping. Clin Pharmacol Ther. 2002;72(6):718–28.
4. Kaneko S, Kurahashi K, Fujita S, Fukushima Y, Sato T, Hill RG. Potentiation of GABA by midazolam and its therapeutic effect against status epilepticus. Folia Psychiatr Neurol Jpn. 1983;37(3):307–9.
5. Sanchez Fernandez I, Loddenkemper T. Therapeutic choices in convulsive status epilepticus. Expert Opin Pharmacother. 2015;16(4):487–500.